Pharmaceutical composition for treating animal babesiasis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A pyrosomiasis and composition technology, applied in the field of pharmaceutical compositions, can solve the problems of high toxicity and side effects, low safety index, etc., and achieve the effects of blocking the metabolism of worms, reducing persistent high fever, and accelerating the function of the gastrointestinal tract
Inactive Publication Date: 2016-05-18
王树青
View PDF3 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, injections such as acaprine, midazolone, and artemether are generally used to treat animal pyroglycosis, but side effects such as restlessness in standing and lyin
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0009] A pharmaceutical composition for treating animal pyrosomiasis, which is composed of the following raw materials: 110g of Artemisia annua, 90g of Capillary, 90g of Rhubarb, 90g of Gentiana, 90g of Bupleurum, 90g of Chinese Angelica, 50g of Akebia, and 50g of Alisma , Atractylodes macrocephala 60g, Poria cocos 60g, licorice 50g.
[0010] When using, add 1.5-2 times the amount of water (the amount of water is preferably 2-3cm soaked in the drug) and decoct for 30 minutes, 200-500ml per head of affected cattle, 1 dose per day, consecutively for 5 days; 100-200ml, 1 dose per day, for 5 consecutive days. When other animals are used, the usage amount of the pharmaceutical composition is adjusted according to the weight ratio of cattle and sheep.
Embodiment 2
[0012] A pharmaceutical composition for treating animal pyrosomiasis, which is composed of the following raw materials: 105g of Artemisia annua, 95g of Capillary chinensis, 95g of rhubarb, 100g of gentian, 100g of bupleurum, 100g of wine angelica, 45g of akebia, and 50g of Alisma , Atractylodes macrocephala 60g, Poria cocos 50g, licorice 40g.
[0013] When using, add 1.5-2 times the amount of water (the amount of water is preferably 2-3cm soaked in the drug) and decoct for 30 minutes, 200-500ml per head of affected cattle, 1 dose per day, consecutively for 5 days; 100-200ml, 1 dose per day, for 5 consecutive days. When other animals are used, the usage amount of the pharmaceutical composition is adjusted according to the weight ratio of cattle and sheep.
Embodiment 3
[0015] A pharmaceutical composition for treating animal pyrosomiasis, which is composed of the following raw materials: 100g of Artemisia annua, 100g of Capillary chinensis, 90g of rhubarb, 95g of gentian, 95g of bupleurum, 90g of wine angelica, 50g of akebia, and 45g of Alisma , Atractylodes macrocephala 50g, Poria cocos 60g, licorice 45g.
[0016] When using, add 1.5-2 times the amount of water (the amount of water is preferably 2-3cm soaked in the drug) and decoct for 30 minutes, 200-500ml per head of affected cattle, 1 dose per day, consecutively for 5 days; 100-200ml, 1 dose per day, for 5 consecutive days. When other animals are used, the usage amount of the pharmaceutical composition is adjusted according to the weight ratio of cattle and sheep.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a pharmaceutical composition for treating animal babesiasis. The pharmaceutical composition consists of artemisia apiacea, Tibetan capillary, rheum officinale, gentian, radix bupleuri, Chinese angelica root, akebia stem, rhizoma alismatis, rhizoma atractylodis macrocephalae, poria cocos and liquorice, wherein the artemisia apiacea is used for preventing malaria and clearing heat; the Tibetan capillary, rheum officinale, gentian and the like have the functions of removing toxicity, eliminating dampness and removing jaundice; the rhizoma alismatis and akebia stem have the functions of discharging heat and inducing diuresis; the radix bupleuri is used for soothing the liver and clearing heat while the Chinese angelica root is used for tonifying and activating blood; and the poria cocos and rhizoma atractylodis macrocephalae are used for invigorating the spleen and promoting appetite. The traditional Chinese medicine components supplement each other and cooperate to generate a synergistic effect to inhibit the DNA synthesis of babesiasis matrix, block metabolism in the babesiasis and inhibit the growth and propagation thereof, so that various symptoms such as alternate lasting high fever, anemia, jaundice, constipation and diarrhea as well as obvious emaciation of the ill animals can be effectively relieved; moreover, the pharmaceutical composition has the functions of clearing heat and removing toxicity, promoting bile secretion and dispelling babesiasis, discharging heat and cooling blood, nourishing yin and moistening dryness, activating blood and resolving stasis and tonifying blood and invigorating the stomach, and can realize perfect effects of invigorating the stomach, regulating qi and tonifying deficiency and accelerate the recovery of gastrointestinal function after babesiasis dispelling; and by reinforcing healthy qi and eliminating pathogen and treating both symptoms and root causes, the pharmaceutical composition is safe without side effects.
Description
technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating animal pyrosomiasis. Background technique [0002] Pyrosomiasis is a kind of protozoan disease caused by pyrozoites parasitizing in animal red blood cells and reticuloendothelial cells, and it is a natural foci disease. In addition to cattle and sheep, the animals it infects include equine animals, dogs, pigs, etc., and sometimes it can infect humans, but the most important target of the disease is cattle and sheep. Since 1995, the disease has been very prevalent in Tianzhu County, Gansu Province, especially in towns such as Tanshanling, Saishisi, Tiantang, and Sailalong. The incidence rate of calves is about 44%, and the fatality rate is 35%. In order to investigate clearly the types of coyoriasis and infectious agents in Tianzhu white yaks, serum and anticoagulant blood samples were collected from white yaks in the high-incidence areas o...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more